Trade Eargo, Inc. - EAR CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0272 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 0.01 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Eargo Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 2.5714 |
Open* | 2.5614 |
1-Year Change* | 292.37% |
Day's Range* | 2.5514 - 2.5614 |
52 wk Range | 1.47-16.80 |
Average Volume (10 days) | 43.85K |
Average Volume (3 months) | 2.15M |
Market Cap | 52.94M |
P/E Ratio | -100.00K |
Shares Outstanding | 20.76M |
Revenue | 41.11M |
EPS | -7.50 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Mar 21, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 2.5714 | -0.0200 | -0.77% | 2.5914 | 2.6014 | 2.5614 |
Dec 7, 2023 | 2.5914 | 0.0000 | 0.00% | 2.5914 | 2.5914 | 2.5914 |
Dec 6, 2023 | 2.6014 | 0.0200 | 0.77% | 2.5814 | 2.6114 | 2.5714 |
Dec 5, 2023 | 2.5914 | 0.0100 | 0.39% | 2.5814 | 2.5914 | 2.5814 |
Dec 4, 2023 | 2.5914 | 0.0100 | 0.39% | 2.5814 | 2.5914 | 2.5514 |
Dec 1, 2023 | 2.5814 | 0.0200 | 0.78% | 2.5614 | 2.5814 | 2.5614 |
Nov 30, 2023 | 2.5914 | 0.0200 | 0.78% | 2.5714 | 2.5914 | 2.5714 |
Nov 29, 2023 | 2.5914 | 0.0300 | 1.17% | 2.5614 | 2.6014 | 2.5614 |
Nov 28, 2023 | 2.5914 | 0.0400 | 1.57% | 2.5514 | 2.5914 | 2.5514 |
Nov 27, 2023 | 2.5814 | 0.0300 | 1.18% | 2.5514 | 2.5814 | 2.5414 |
Nov 24, 2023 | 2.5614 | 0.0400 | 1.59% | 2.5214 | 2.5714 | 2.5214 |
Nov 22, 2023 | 2.5414 | 0.0000 | 0.00% | 2.5414 | 2.5514 | 2.5214 |
Nov 21, 2023 | 2.5414 | -0.0100 | -0.39% | 2.5514 | 2.5814 | 2.5414 |
Nov 20, 2023 | 2.5814 | 0.0300 | 1.18% | 2.5514 | 2.5814 | 2.5514 |
Nov 17, 2023 | 2.5514 | 0.0000 | 0.00% | 2.5514 | 2.5514 | 2.5414 |
Nov 16, 2023 | 2.5414 | 0.0000 | 0.00% | 2.5414 | 2.5414 | 2.5414 |
Nov 15, 2023 | 2.5414 | 0.0000 | 0.00% | 2.5414 | 2.5514 | 2.5314 |
Nov 14, 2023 | 2.5514 | 0.0100 | 0.39% | 2.5414 | 2.5514 | 2.5414 |
Nov 13, 2023 | 2.5414 | 0.0000 | 0.00% | 2.5414 | 2.5514 | 2.5414 |
Nov 10, 2023 | 2.5414 | 0.0200 | 0.79% | 2.5214 | 2.5414 | 2.5214 |
Eargo, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, March 21, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q4 2023 Eargo Inc Earnings Release Q4 2023 Eargo Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 37.248 | 66.522 | 69.154 | 32.79 | 23.163 |
Revenue | 37.248 | 66.522 | 69.154 | 32.79 | 23.163 |
Cost of Revenue, Total | 22.988 | 27.956 | 21.873 | 15.79 | 11.423 |
Gross Profit | 14.26 | 38.566 | 47.281 | 17 | 11.74 |
Total Operating Expense | 149.779 | 223.229 | 105.652 | 76.826 | 55.293 |
Selling/General/Admin. Expenses, Total | 107.206 | 135.641 | 70.107 | 48.195 | 33.791 |
Research & Development | 18.813 | 25.232 | 12.045 | 12.841 | 9.52 |
Unusual Expense (Income) | 0.772 | 34.4 | 1.627 | 0 | 0.559 |
Operating Income | -112.531 | -156.707 | -36.498 | -44.036 | -32.13 |
Interest Income (Expense), Net Non-Operating | -44.856 | -1.047 | -1.883 | -0.084 | -0.26 |
Other, Net | 0 | 0 | -1.474 | -0.366 | -1.403 |
Net Income Before Taxes | -157.387 | -157.754 | -39.855 | -44.486 | -33.793 |
Net Income After Taxes | -157.487 | -157.754 | -39.855 | -44.486 | -33.793 |
Net Income Before Extra. Items | -157.487 | -157.754 | -39.855 | -44.486 | -33.793 |
Net Income | -157.487 | -157.754 | -39.855 | -44.486 | -33.793 |
Income Available to Common Excl. Extra. Items | -157.487 | -157.754 | -30.015 | -44.486 | -33.766 |
Income Available to Common Incl. Extra. Items | -157.487 | -157.754 | -30.015 | -44.486 | -33.766 |
Diluted Net Income | -157.487 | -157.754 | -30.015 | -44.486 | -33.766 |
Diluted Weighted Average Shares | 3.96843 | 1.94497 | 1.91233 | 4.27156 | 4.27156 |
Diluted EPS Excluding Extraordinary Items | -39.6849 | -81.1086 | -15.6955 | -10.4145 | -7.90484 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Diluted Normalized EPS | -39.5585 | -63.422 | -14.8447 | -10.4145 | -7.77398 |
Total Adjustments to Net Income | 0 | 0 | 9.84 | 0 | 0.027 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 8.108 | 11.813 | 12.917 | 7.908 | 7.247 |
Revenue | 8.108 | 11.813 | 12.917 | 7.908 | 7.247 |
Cost of Revenue, Total | 6.477 | 6.691 | 6.757 | 6.007 | 4.733 |
Gross Profit | 1.631 | 5.122 | 6.16 | 1.901 | 2.514 |
Total Operating Expense | 33.914 | 34.605 | 36.801 | 33.954 | 39.462 |
Selling/General/Admin. Expenses, Total | 22.073 | 23.309 | 25.92 | 22.984 | 30.078 |
Research & Development | 5.364 | 4.605 | 4.124 | 4.963 | 3.879 |
Operating Income | -25.806 | -22.792 | -23.884 | -26.046 | -32.215 |
Interest Income (Expense), Net Non-Operating | 0.654 | 0.87 | -19.787 | -24.581 | -0.229 |
Other, Net | 0 | ||||
Net Income Before Taxes | -25.152 | -21.922 | -43.671 | -50.627 | -32.444 |
Net Income After Taxes | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Net Income Before Extra. Items | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Net Income | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Income Available to Common Excl. Extra. Items | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Income Available to Common Incl. Extra. Items | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Diluted Net Income | -25.152 | -21.922 | -43.771 | -50.627 | -32.444 |
Diluted Weighted Average Shares | 20.7458 | 20.7344 | 9.96944 | 1.96987 | 1.96821 |
Diluted EPS Excluding Extraordinary Items | -1.21239 | -1.05728 | -4.39052 | -25.7007 | -16.484 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -1.21239 | -1.05728 | -4.39052 | -25.7007 | -16.0917 |
Unusual Expense (Income) | 0 | 0 | 0 | 0.772 | |
Total Adjustments to Net Income | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 116.03 | 139.632 | 222.457 | 19.913 | 55.689 |
Cash and Short Term Investments | 101.238 | 110.5 | 212.185 | 13.384 | 51.051 |
Cash & Equivalents | 101.238 | 110.5 | 212.185 | 13.384 | 51.051 |
Total Receivables, Net | 1.91 | 12.547 | 3.793 | 2.051 | 0.965 |
Accounts Receivable - Trade, Net | 1.91 | 12.547 | 3.793 | 2.051 | 0.965 |
Total Inventory | 5.036 | 5.712 | 2.739 | 2.88 | 2.16 |
Prepaid Expenses | 7.846 | 10.873 | 3.74 | 1.598 | 1.363 |
Other Current Assets, Total | 0 | 0.15 | |||
Total Assets | 132.078 | 160.111 | 232.632 | 27.305 | 59.042 |
Property/Plant/Equipment, Total - Net | 13.206 | 16.716 | 9.113 | 5.4 | 2.949 |
Property/Plant/Equipment, Total - Gross | 26.346 | 25.614 | 14.2 | 8.119 | 4.16 |
Accumulated Depreciation, Total | -13.14 | -8.898 | -5.087 | -2.719 | -1.211 |
Other Long Term Assets, Total | 0.906 | 1.209 | 1.062 | 1.992 | 0.404 |
Total Current Liabilities | 25.251 | 72.383 | 23.718 | 22.29 | 12.66 |
Accounts Payable | 6.504 | 9.053 | 6.02 | 5.428 | 5.175 |
Accrued Expenses | 12.763 | 9.609 | 14.358 | 9.939 | 5.723 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 3.333 | 0 | 4.8 | 0 |
Other Current Liabilities, Total | 5.984 | 50.388 | 3.34 | 2.123 | 1.762 |
Total Liabilities | 31.224 | 90.947 | 38.721 | 30.528 | 20.026 |
Total Long Term Debt | 0 | 11.924 | 14.837 | 7.842 | 7.071 |
Long Term Debt | 0 | 11.924 | 14.837 | 7.842 | 7.071 |
Other Liabilities, Total | 5.973 | 6.64 | 0.166 | 0.396 | 0.295 |
Total Equity | 100.854 | 69.164 | 193.911 | -3.223 | 39.016 |
Redeemable Preferred Stock | 0 | 0 | 0 | 152.88 | 152.015 |
Common Stock | 0.002 | 0.004 | 0.004 | 0 | 0 |
Additional Paid-In Capital | 615.151 | 425.972 | 392.965 | 3.1 | 1.718 |
Retained Earnings (Accumulated Deficit) | -514.299 | -356.812 | -199.058 | -159.203 | -114.717 |
Total Liabilities & Shareholders’ Equity | 132.078 | 160.111 | 232.632 | 27.305 | 59.042 |
Total Common Shares Outstanding | 20.727 | 1.96536 | 1.91233 | 4.27156 | 4.27156 |
Goodwill, Net | 0.873 | 0.873 | |||
Intangibles, Net | 1.063 | 1.681 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 56.692 | 72.935 | 97.637 | 116.03 | 99.242 |
Cash and Short Term Investments | 46.023 | 60.779 | 79.776 | 101.238 | 88.075 |
Cash & Equivalents | 46.023 | 60.779 | 79.776 | 101.238 | 88.075 |
Total Receivables, Net | 1.012 | 0.961 | 1.92 | 1.91 | 1.156 |
Accounts Receivable - Trade, Net | 1.012 | 0.961 | 1.92 | 1.91 | 1.156 |
Total Inventory | 4.386 | 5.36 | 4.837 | 5.036 | 4.953 |
Prepaid Expenses | 5.271 | 5.835 | 11.104 | 7.846 | 5.058 |
Total Assets | 69.753 | 87.55 | 114.51 | 132.078 | 116.57 |
Property/Plant/Equipment, Total - Net | 11.711 | 12.168 | 14.265 | 13.206 | 15.028 |
Property/Plant/Equipment, Total - Gross | 27.79 | 27.384 | 28.578 | 26.346 | 26.889 |
Accumulated Depreciation, Total | -16.079 | -15.216 | -14.313 | -13.14 | -11.861 |
Other Long Term Assets, Total | 0.606 | 0.724 | 0.779 | 0.906 | 0.21 |
Total Current Liabilities | 17.594 | 20.523 | 25.004 | 25.251 | 146.719 |
Accounts Payable | 5.047 | 3.729 | 8.976 | 6.504 | 6.396 |
Accrued Expenses | 7.203 | 9.777 | 8.17 | 12.763 | 11.247 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 5.344 | 7.017 | 7.858 | 5.984 | 4.076 |
Total Liabilities | 24.624 | 27.733 | 32.17 | 31.224 | 152.894 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | 0 | |||
Other Liabilities, Total | 7.03 | 7.21 | 7.166 | 5.973 | 6.175 |
Total Equity | 45.129 | 59.817 | 82.34 | 100.854 | -36.324 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.002 | 0.002 | 0.002 | 0.002 | 0.004 |
Additional Paid-In Capital | 623.828 | 621.188 | 618.559 | 615.151 | 434.2 |
Retained Earnings (Accumulated Deficit) | -578.701 | -561.373 | -536.221 | -514.299 | -470.528 |
Total Liabilities & Shareholders’ Equity | 69.753 | 87.55 | 114.51 | 132.078 | 116.57 |
Total Common Shares Outstanding | 20.7624 | 20.7496 | 20.7418 | 20.727 | 1.97055 |
Goodwill, Net | 0 | 0.873 | 0.873 | 0.873 | 0.873 |
Intangibles, Net | 0.744 | 0.85 | 0.956 | 1.063 | 1.217 |
Current Port. of LT Debt/Capital Leases | 0 | 125 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -157.487 | -157.754 | -39.855 | -44.486 | -33.793 |
Cash From Operating Activities | -117.304 | -98.456 | -26.041 | -39.108 | -27.149 |
Cash From Operating Activities | 5.458 | 4.202 | 2.525 | 1.528 | 0.695 |
Non-Cash Items | 63.954 | 38.984 | 13.18 | 1.934 | 1.643 |
Cash Interest Paid | 0.396 | 0.646 | 0.398 | 0.395 | 0.563 |
Changes in Working Capital | -29.229 | 16.112 | -1.891 | 1.916 | 4.306 |
Cash From Investing Activities | -3.087 | -7.587 | -5.079 | -3.859 | -2.547 |
Capital Expenditures | -3.087 | -4.724 | -5.079 | -3.859 | -2.547 |
Cash From Financing Activities | 111.129 | 4.358 | 229.921 | 5.15 | 71.728 |
Financing Cash Flow Items | -0.098 | -0.04 | -2.614 | -0.758 | 0 |
Issuance (Retirement) of Stock, Net | 27.732 | 4.398 | 220.202 | 0.908 | 72.417 |
Issuance (Retirement) of Debt, Net | 83.495 | 0 | 12.333 | 5 | -0.689 |
Net Change in Cash | -9.262 | -101.685 | 198.801 | -37.817 | 42.032 |
Cash Taxes Paid | 0.124 | 0.107 | 0.063 | ||
Other Investing Cash Flow Items, Total | 0 | -2.863 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -21.922 | -157.487 | -113.716 | -63.089 | -30.645 |
Cash From Operating Activities | -21.33 | -117.304 | -96.862 | -82.882 | -20.35 |
Cash From Operating Activities | 1.28 | 5.458 | 4.023 | 2.713 | 1.419 |
Non-Cash Items | 3.757 | 63.954 | 40.587 | 12.232 | 3.663 |
Cash Taxes Paid | |||||
Cash Interest Paid | |||||
Changes in Working Capital | -4.445 | -29.229 | -27.756 | -34.738 | 5.213 |
Cash From Investing Activities | -0.132 | -3.087 | -2.827 | -2.352 | -0.942 |
Capital Expenditures | -0.132 | -3.087 | -2.827 | -2.352 | -0.942 |
Cash From Financing Activities | 0 | 111.129 | 77.264 | 81.364 | 0.024 |
Issuance (Retirement) of Stock, Net | 0 | 27.732 | 0.134 | 0.125 | 0.093 |
Issuance (Retirement) of Debt, Net | 83.495 | 78.1 | 81.33 | ||
Net Change in Cash | -21.462 | -9.262 | -22.425 | -3.87 | -21.268 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | ||
Financing Cash Flow Items | 0 | -0.098 | -0.97 | -0.091 | -0.069 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Patient Square Capital, LP | Private Equity | 76.2488 | 15821299 | 0 | 2023-06-30 | MED |
The Charles and Helen Schwab Living Trust | Corporation | 5.226 | 1084371 | 0 | 2023-03-31 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.1217 | 232744 | -49188 | 2023-06-30 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 1.0019 | 207886 | -18114 | 2023-06-30 | LOW |
Nan Fung Life Sciences | Venture Capital | 0.7128 | 147904 | 0 | 2023-06-30 | LOW |
Gilde Healthcare Partners B.V. | Venture Capital | 0.4504 | 93465 | -56369 | 2022-10-11 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.411 | 85290 | 15766 | 2023-06-30 | LOW |
Nantahala Capital Management, LLC | Hedge Fund | 0.2603 | 54002 | 0 | 2023-06-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.2491 | 51685 | 0 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.224 | 46480 | -2700 | 2023-06-30 | HIGH |
Wu (David James) | Individual Investor | 0.1227 | 25463 | 0 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.0907 | 18813 | -17277 | 2023-06-30 | HIGH |
BofA Global Research (US) | Research Firm | 0.0571 | 11844 | 51 | 2023-06-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.0442 | 9173 | 0 | 2023-06-30 | LOW |
CIBC Asset Management Inc. | Investment Advisor | 0.042 | 8715 | 0 | 2023-06-30 | LOW |
CSS, LLC | Investment Advisor | 0.0417 | 8656 | 250 | 2023-06-30 | HIGH |
Brownie (William H) | Individual Investor | 0.0307 | 6366 | -1514 | 2023-08-17 | LOW |
Hughes (Douglas J) | Individual Investor | 0.0258 | 5353 | 3568 | 2022-11-22 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.0245 | 5086 | 0 | 2023-06-30 | MED |
Gormsen (Christian) | Individual Investor | 0.0231 | 4795 | -58 | 2023-05-17 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Eargo, Inc. Company profile
Eargo (EAR) is a medical device company headquartered in San Jose, California. The company’s hearing loss solutions bring together proprietary technology, on-demand, licensed, hearing professionals and advanced personalised apps.
The company’s offering includes several hearing aid products such as the Eargo 6, Eargo 5, Eargo Neo HiFi and the Eargo Max.
Eargo stock was listed on the Nasdaq Stock Exchange under the ticker symbol EAR. The company’s initial public offering (IPO) took place on 16 October 2020, offering 7.9 million common shares each priced at $18. The IPO was upsized from the company’s original offering of nearly 6.7 million common stock shares priced between $14 and $16.
As of August 2022, Eargo does not pay a dividend to shareholders.
You can follow the ups and downs of the Eargo stock price at Capital.com. Always stay on top of the latest price developments with our live EAR stock price chart.
Industry: | Advanced Medical Equipment & Technology (NEC) |
2665 North First Street
Suite 300
95134
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com